Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesMEX:GEHC -4.79%63 5-Year Yield-on-Cost % is 0.22 as of Jul. 16, 2026, which is 47% above its 10-year median of 0.15. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,477.73 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 325 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 94.46% on this metric.
The historical rank and industry rank for GE HealthCare Technologies's 5-Year Yield-on-Cost % or its related term are showing as below:
MEX:GEHC'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.04 Med: 0.15 Max: 0.29
Current: 0.22
During the past 7 years, GE HealthCare Technologies's highest Yield on Cost was 0.29. The lowest was 0.04. And the median was 0.15.
MEX:GEHC's 5-Year Yield-on-Cost % is ranked worse than 94.46% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs MEX:GEHC: 0.22
GE HealthCare Technologies (MEX:GEHC) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
GE HealthCare Technologies 5-Year Yield-on-Cost % Related Terms
MEX:GEHC vs DXCM, STE, ZBH: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's 5-Year Yield-on-Cost % falls into.
GE HealthCare Technologies 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
GE HealthCare Technologies (MEX:GEHC) has a 5-Year Yield-on-Cost % of 0.22 as of Jul. 16, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GE HealthCare Technologies and its competitors. This is 47% above median its historical median of 0.15. Over the past decade, GE HealthCare Technologies' 5-Year Yield-on-Cost % has ranged from 0.04 to 0.29. According to the industry distribution chart, GE HealthCare Technologies ranks #307 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 94.5%.
Is GE HealthCare Technologies' 5-Year Yield-on-Cost % too high?
GE HealthCare Technologies' current 5-Year Yield-on-Cost % of 0.22 is 47% above median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 0.29. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. GE HealthCare Technologies' value of 0.22 is 90.5% below this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #307 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' 5-Year Yield-on-Cost % compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #307 out of 325 companies for 5-Year Yield-on-Cost %. This places GE HealthCare Technologies in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. GE HealthCare Technologies' value of 0.22 is 90.5% below this benchmark. Historically, GE HealthCare Technologies' own 5-Year Yield-on-Cost % has ranged from 0.04 to 0.29 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 2.31, GE HealthCare Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current 5-Year Yield-on-Cost % of 0.22 is 90.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current 5-Year Yield-on-Cost % is 0.22, which is 47% above median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,477.73, compared to a current price of MXN1,094.87 — trading 25.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.22, which is 47% above median its 10-year median of 0.15 and 90.5% below the Medical Devices & Instruments industry median of 2.31. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current 5-Year Yield-on-Cost % is 0.22 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,094.87 is trading 25.9% below its estimated GF Value™ of MXN1,477.73.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
5-Year Yield-on-Cost %: 0.22 (47% above median its 10-year median of 0.15)
GF Value™: MXN1,477.73 vs. price of MXN1,094.87 (25.9% below fair value)
Industry Position: 90.5% below the Medical Devices & Instruments median (#307 of 325)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score
Get the complete analysis for MEX:GEHC
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
